CMV DNA was undetectable in all plasma samples tested during the study. CMV-specific antibody titres declined during letermovir treatment but started rising again after the drug was stopped, ...
7h
DelveInsight's "LUXTURNA Market Size, Forecast, and Market Insight Report" highlights the details around LUXTURNA, a one-time ...
LUXTURNA has significant market potential due to the high unmet need for effective treatments in rare genetic conditions. With its FDA approval for specific mutations in the RPE65 gene, it offers ...
Cytomegalovirus (CMV) infection/reactivation has ... Consider the benefit versus risks of treatment with a PD-1/PD-L1 blocking antibody prior to or after an allogeneic HSCT. Embryo-Fetal Toxicity ...
Beyond its composition – which consists of water, salts, enzymes, antibodies and other proteins – plasma ... therapeutic for ...
Treatment with prednisone ... the bilirubin levels were normal. Antinuclear antibody testing was positive at a titer of 1:40. Results of serum protein electrophoresis were normal, as were levels ...
Two groups of mice were sleep deprived for 4 h (SD4) or exposed to SPS treatment, respectively ... The sections were incubated with rabbit anti-c-Fos antibody (1:2,500, EMD Millipore, ABE457) in ...
The company has dramatically reduced the cost of CMV prophylaxis by 91 per cent, bringing down the monthly treatment price from over ₹5 lakh to a substantially more affordable level. ANVIMO is ...
Antibody treatment which activates the patient's own immune system against cancer, known as immunotherapy, is increasingly being investigated as an alternative for chemotherapy and radiotherapy.
The Food and Drug Administration has approved more than 100 monoclonal antibodies to treat a range of diseases. Other ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback